We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
AUM
$9.16B
AUM Growth
-$13.2B
Cap. Flow
-$10.8B
Cap. Flow %
-117.92%
Top 10 Hldgs %
34.38%
Holding
2,371
New
451
Increased
532
Reduced
695
Closed
657

Sector Composition

Rank Sector Weight
1 Technology 8.09%
2 Financials 7.11%
3 Healthcare 5.24%
4 Communication Services 5.21%
5 Consumer Discretionary 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTLA icon
1626
Intellia Therapeutics
NTLA
$1.68B
$137K ﹤0.01%
15,202
-48,952
-76% -$674K
DSP icon
1627
Viant Technology
DSP
$282M
$137K ﹤0.01%
+11,340
New +$113K
EHAB
1628
DELISTED
Enhabit
EHAB
$136K ﹤0.01%
+14,707
New +$127K
AUR icon
1629
Aurora
AUR
$13.7B
$135K ﹤0.01%
+35,124
New +$161K
ZVRA icon
1630
Zevra Therapeutics
ZVRA
$682M
$133K ﹤0.01%
14,893
-115,858
-89% -$1.1M
ACCO icon
1631
Acco Brands
ACCO
$402M
$132K ﹤0.01%
+35,448
New +$131K
KOS icon
1632
Kosmos Energy
KOS
$1.49B
$132K ﹤0.01%
145,695
-3,733
-2% -$4.92K
TTI icon
1633
TETRA Technologies
TTI
$1.28B
$128K ﹤0.01%
13,618
-22,193
-62% -$171K
ALTI icon
1634
AlTi Global
ALTI
$476M
$127K ﹤0.01%
27,600
-11,727
-30% -$48.4K
MDXG icon
1635
MiMedx Group
MDXG
$622M
$126K ﹤0.01%
+18,585
New +$130K
MBI icon
1636
MBIA
MBI
$256M
$125K ﹤0.01%
+17,456
New +$126K
EBS icon
1637
Emergent Biosolutions
EBS
$229M
$125K ﹤0.01%
10,087
-3,813
-27% -$40.9K
CTOS icon
1638
Custom Truck One Source
CTOS
$2.42B
$123K ﹤0.01%
+21,413
New +$131K
RES icon
1639
RPC Inc
RES
$1.36B
$123K ﹤0.01%
+22,637
New +$118K
WOOF icon
1640
Petco
WOOF
$765M
$120K ﹤0.01%
42,776
-35,890
-46% -$116K
FIGS icon
1641
FIGS
FIGS
$2.39B
$117K ﹤0.01%
10,311
-5,157
-33% -$48.3K
ABEO icon
1642
Abeona Therapeutics
ABEO
$425M
$114K ﹤0.01%
+21,707
New +$109K
ABR icon
1643
Arbor Realty Trust
ABR
$1,000M
$114K ﹤0.01%
+14,700
New +$144K
CGEM icon
1644
Cullinan Oncology
CGEM
$1.18B
$114K ﹤0.01%
10,970
-34,966
-76% -$315K
SBET icon
1645
Sharplink Inc
SBET
$1.3B
$113K ﹤0.01%
+12,654
New +$155K
PGEN icon
1646
Precigen
PGEN
$2.51B
$110K ﹤0.01%
26,267
-97,475
-79% -$377K
XIFR
1647
XPLR Infrastructure LP
XIFR
$1.07B
$108K ﹤0.01%
10,815
-48,999
-82% -$475K
OPK icon
1648
Opko Health
OPK
$1.04B
$108K ﹤0.01%
+85,348
New +$119K
QTRX icon
1649
Quanterix
QTRX
$114M
$107K ﹤0.01%
16,800
-6,444
-28% -$40K
EGHT icon
1650
8x8 Inc
EGHT
$324M
$102K ﹤0.01%
+51,759
New +$102K

Similar funds

Brevan Howard Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Brevan Howard Capital Management held 2,371 positions worth $9.16B, down 59% from $22.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Brevan Howard Capital Management withdrew a net $10.8B in Q4 2025, closing 657 positions and reducing 695 holdings. Its most notable exit was Insmed, an estimated $42.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 4.4% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Brevan Howard Capital Management opened a new position in First Trust Small Cap BuyWrite Income ETF worth $452M.

  • Brevan Howard Capital Management's largest Q4 2025 buy was First Trust Small Cap BuyWrite Income ETF: 57,081,120 shares worth $452M.
  • Brevan Howard Capital Management added most to Walmart Inc in Q4 2025, an estimated $84M increase.
  • Brevan Howard Capital Management's biggest Q4 2025 reduction was iShares Bitcoin Trust, cutting an estimated $1.77B.
  • Brevan Howard Capital Management fully exited Insmed in Q4 2025, selling an estimated $42.3M.
  • Brevan Howard Capital Management's ten largest holdings make up 34% of its $9.16B portfolio in Q4 2025.
  • Brevan Howard Capital Management opened 451 new positions and closed 657 in Q4 2025.
  • Brevan Howard Capital Management's portfolio value fell 59% quarter-over-quarter to $9.16B.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.